Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsLancet Respir Med - Mayer-Hamblett, N; Ratjen, F; Russell, R (2023)
et al.